Canada markets open in 5 hours 15 minutes

  • S&P/TSX

    19,203.70
    +2.40 (+0.01%)
     

  • S&P 500

    4,141.59
    +13.60 (+0.33%)
     

  • DOW

    33,677.27
    -68.13 (-0.20%)
     

  • CAD/USD

    0.7966
    -0.0015 (-0.19%)
     

  • CRUDE OIL

    60.95
    +0.77 (+1.28%)
     

  • BTC-CAD

    81,137.78
    +4,436.52 (+5.78%)
     

  • CMC Crypto 200

    1,396.64
    +102.65 (+7.93%)
     

  • GOLD FUTURES

    1,745.40
    -2.20 (-0.13%)
     

  • RUSSELL 2000

    2,228.92
    -4.86 (-0.22%)
     

  • 10-Yr Bond

    1.6230
    0.0000 (0.00%)
     

  • NASDAQ futures

    13,978.25
    +2.50 (+0.02%)
     

  • VOLATILITY

    16.74
    -0.17 (-1.01%)
     

  • FTSE

    6,894.71
    +4.22 (+0.06%)
     

  • NIKKEI 225

    29,620.99
    +82.29 (+0.28%)
     

  • CAD/EUR

    0.6655
    -0.0018 (-0.27%)
     

Chris Paul with an assist vs the Los Angeles Lakers

Chris Paul (Phoenix Suns) with an assist vs the Los Angeles Lakers, 03/02/2021

Latest Stories

  • New Hires to Boost RegTech Provider Napier’s Global Growth Activity

    Fast growing RegTech company, Napier, which provides next-generation anti-money laundering (AML) solutions, has bolstered its senior management team with the appointments of new Global Human Resources Director, Lila Boyce, and EMEA Head of Sales, Roy Williamson.

  • How the 'entitlement gap' is holding women back at work

    The entitlement gap is when men have a greater sense of entitlement to career markers such as promotions, pay-rises and big projects.

  • Global Clinical Genomics Markets Report 2021: Mergers, Acquisitions, and Partnerships Accelerate Adoption of Clinical Genomics

    Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics" report has been added to ResearchAndMarkets.com's offering. This "Clinical Genomics Report: The Interplay Between Clinical Research and Clinic Diagnostics" provides an in-depth analysis of differences in product characteristics related to data processing, analysis, knowledge extraction and reporting of findings (including the type of content integrated for meaningful extraction), and compliance and security mechanisms. Both clinical end-users and commercial companies who require insight into this expanding industry and its providers and products will benefit from the critical, investigative, and qualitative report. This new, qualitative report provides an in-depth analysis across the complex, multi-step clinical genomics data process (which includes genomic data generation, data flow, and data warehousing), clinical genomics data solution providers, market trends, technologies impacting clinical genomics applications development, clinical genomics adoption challenges, and detailed challenges & needs analysis as identified in discussions with clinical end-users. The report is unique, in that it is not a predictive market research report, but rather builds on data gathered from many end-user interviews combined with an extensive analysis of the clinical genomics sector. Report Contents: Leading medical organizations have established precision medicine programs that support personalized patient treatment. Implementation of clinical genomics applications and enterprise-wide clinical data warehouses are considered the foundation for successful genomic medicine programs. Innovative technological advancements have allowed us to sequence and uncover mutational events at an unprecedented scale while facilitating linking genomic data to high-quality clinical data and diagnosis. Medical organizations understand the benefit of being empowered by data-driven approaches to reduce operational costs and time and to provide researchers and clinicians what is necessary to decipher critical research data and data for clinical decision making. However, technical and scientific limitations still need to be addressed for optimized and universal use of various data sources for both clinical and research purposes. While data production is no longer a challenge, and targeted panels - and to some extent, whole-exome sequencing - are well adopted, the expected dramatic rise in whole-genome sequencing will result in unforeseeable quantities of data at the clinical level that needs to be managed, understood, and communicated. Low-cost sequencing of whole genomes at population scale is already in existence, but not yet widespread in the clinic, as many observed changes at the genome level cannot yet be fully interpreted or explain an existing phenotype. Scalable, fully automated analysis and knowledge extraction solutions incorporating rich annotation information are necessary to overcome these challenges. With massive quantities of NGS data (linked to different clinical and other types of data), artificial intelligence and machine learning are hailed as pivotal solutions to address the data interpretation and knowledge extraction challenges and to advance the clinical application of genomics. Despite increasing efforts and investments in implementing clinical applications and building data solutions, many organizations are still challenged with the multi-faceted complexities in transforming to become data-driven. Implementations are challenged by ineffective data sharing, scalability and automation issues, non-optimized data generation and data flow approaches and non-standardized data from numerous sources. Implementing a complex clinical data warehouse presents many challenges starting with the various data sources it needs to support and the tools required to view the clinical information. Ingestion of data of different types and origins with relevant metadata; data transformation, standardization, and cleansing to support the needs of a diverse set of end-users in both the clinical and research settings; and varied end-users with individual needs and computation capabilities are all important considerations. Clinical interviews detailed challenges associated with creating a workflow that incorporates a clinical data warehouse connecting clinical research with clinical diagnostics and vice versa. This important workflow leads to efficient clinical decision-making and reporting findings between clinical research and the clinic, which can optimize clinical outcomes and patient treatment. Key Topics Covered: 1. THE CLINICAL DIAGNOSTICS & MOLECULAR PROFILING WORKFLOW Clinical Genomics Workflow End Users/PersonasMapping End Users to the Clinical Genomics WorkflowClinical Information Delivery 2. THE PRECISION MEDICINE VALUE CHAIN 3. LEADING MEDICAL ORGANIZATIONS PLATFORM AND INFRASTRUCTURE PREFERENCES IN SUPPORT OF THEIR CLINICAL GENOMICS WORKFLOWS Implementations and Choices of Molecular Profiling and Genetic Testing ProcessesMedical Organizations' Clinical Genetic Testing LabsTesting Lab Selection CriteriaPlatforms and Infrastructures Currently Implemented at Leading Medical OrganizationsAdoption of Commercial and Internally Developed Platforms, Tools, and ServicesMedical Organizations Platform and Infrastructure PreferencesProfiles of Leading Medical OrganizationsCedars-SinaiEmory HealthcareGeisinger Health SystemsIntermountain HealthcareKaiser PermanenteMayo ClinicMD Anderson Cancer CenterMoffitt Cancer CenterMount Sinai Health SystemNationwide Children's HospitalPartners HealthCareSanford HealthSt. Jude Children's HospitalVanderbilt University Medical Center 4. MEDICAL INDUSTRY CHALLENGES Clinical Genomics - Unmet Needs and ChallengesTechnical Challenges Associated with Scaling Clinical Genomics ApplicationsScientific Challenges Associated with the Implementation of Clinical GenomicsNon-Technical / Scientific Challenges Associated with the Implementation of Clinical Genomics Applications 5. GENOMIC DATA GENERATION, DATA FLOW, AND DATA WAREHOUSING Rethinking Optimized Genomic Data Generation and Data FlowStructures of Successful Big Data PlatformsScalable Data Generation and Data Flow Lacking Data StandardsSlow Integration of Clinical Genomics Data with Other Clinical/Patient DataCurrent EMR/EHR Systems Do Not Support Genomics DataVariant Data Warehousing for Data Analysis, Mining, and QueryingEnterprise Data Platform ArchitectureIntegration of Various Types of DataA Data Warehouse That Supports Clinical ResearchData Warehousing and Fast Data Processing Requires a Scalable InfrastructureThe Ideal Variant Data Analysis and Query PlatformData Warehouse versus a Data LakeCloud Is the Preferred Infrastructure 6. CLINICAL GENOMICS DATA SOLUTIONS Genomic Data Infrastructures/Platforms for Data Storage, Processing, and AnalysisScaled Data Storage and Computing SolutionsClinical Genomics Data PlatformsIntegrated Genomic WorkflowData Processing Speed, Scalability, and FlexibilityClinical Data Management & Knowledge ExtractionClinico-Genomic Data Management and IntegrationGenomic/Variant Data Querying and AnalysisVariant Data Interpretation/Decision Making/ReportingTertiary Analysis - Sequence Data Interpretation and Insight GenerationTertiary Analysis - Embedded Interpretation Content for Insight GenerationData Processing, Knowledge Extraction, and Reporting Companies Side-by-Side 7. CLINICAL GENOMICS MARKET TRENDS Factors Impacting Clinical Sequencing AdoptionGenetic Testing and Molecular Profiling TrendsThe Increasing Trend of Clinical Genetic TestingClinical Genomics Applications to Be Established in the Clinic as a RoutineRoutine Genomic Applications Established over the Next Three to Five YearsRequirements to Establish Genomic Applications as a RoutineMergers, Acquisitions, and Partnerships Accelerate Adoption of Clinical GenomicsAgilent Is Building Integrated, Complete Clinical Workflow SolutionsIllumina's M&As Suggest the Goal of a Fully Integrated Sequencing SolutionRoche Is Expanding its Diagnostics BusinessThermo Fisher Scientific Is Strengthening Its Presence in the Clinical SectorQIAGEN Is Pushing the Molecular Diagnostics and Clinical Research MarketsOther Acquisitions and Partnerships 8. TECHNOLOGIES IMPACTING THE IMPLEMENTATION OF CLINICAL GENOMICS & MOLECULAR PROFILING APPLICATIONS 3rd and 4th Generation Sequencing TechnologyArtificial Intelligence/Machine Learning ApplicationsAI in Healthcare Adoption DriversLiquid Biopsy in Clinical DiagnosticsLiquid Biopsy Clinical ApplicationsLong-Read Sequencing TechnologyReal-World Data / Real-World EvidenceThe FDA Is Attempting to Define RWD and RWEAn Uptick of RWD and RWE PublicationsThe Benefits of Real-World EvidenceThe Challenges of Using RWD and RWEAn Active Playing Field of Commercial RWD PlayersClinical Genomics Adoption Challenges 9. COVID-19, THE HEALTHCARE DISRUPTER Diagnostics - Commercial Companies RevampingDiagnostics Companies Quickly PivotedCOVID-19, a Disrupter, but also an OpportunityViral Sequencing Reveals How SARSCo-V-2 Evolves and SpreadsCOVID-19 Resulted in Unprecedented Data SharingCOVID-19 and the Massive Disruptions to Clinical Trials Processes 10. COMMERCIAL CLINICAL SOLUTIONS / PRODUCT PROVIDERS Company ProfilesBC PlatformsBluebee (an Illumina company)ColorCongenicaDNAnexusFabric GenomicsFoundation MedicineFreenomeGenooxGenuity ScienceGoogle Life SciencesGRAILHelixIlluminaInvitaePierianDxQIAGENSeven BridgesSOPHiA GeneticsTempus 11. THE FUNDING SITUATION 12. APPENDIX Clinical Genomics End User TypesThe Computational Scientist/BioinformaticianThe Data ScientistThe Non-Computational CollaboratorThe Genetic CounselorThe Clinical GeneticistThe PhysicianThe Patient 13. ABBREVIATIONSFor more information about this report visit https://www.researchandmarkets.com/r/hfqr98 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Jennifer Aniston Adoption Rumours Dismissed By Spokesperson

    Reports claimed the actor told her Friends co-stars of her plans to adopt a baby girl during filming of the reunion special last week.

  • Retired couple scoop EuroMillions win after husband forgets his glasses while buying ticket

    Denis and Ann Fawsitt won over £100,000 as a result of a lucky bout of forgetfulness.

  • Credit Suisse Sells $2 Billion of Archegos-Linked Stocks

    (Bloomberg) -- Credit Suisse Group AG unloaded about $2 billion of stocks tied to the Archegos Capital Management blowup in the second such block sale since the bank wrote down the bulk of its exposure in the first quarter.The stock offerings included Discovery Inc. and Iqiyi Inc., adding to some $2.3 billion worth of shares tied to the debacle that the bank sold last week, according to people familiar with the matter. The trades follow a torrent of similar transactions that had already erased about $194 billion in market value as banks from New York to Zurich and Tokyo unwound leveraged equity bets by Bill Hwang’s family office.Shares of Credit Suisse fell as the sale adds to evidence that the Archegos collapse could impact the bank beyond the first quarter, when it took a 4.4 billion franc ($4.8 billion) writedown, its worst trading hit in more than a decade. While the Swiss bank has substantially reduced its exposure, transactions since the end of March weren’t included in the first-quarter results, a person familiar with the matter has said.Credit Suisse fell as much as 2.2% in early Zurich trading and was 1.2% lower by 9:43 a.m. The stock has lost 15% this year, compared with double-digit gains for an index that includes its European peers.A spokesperson for Credit Suisse declined to comment on the sale and whether the bank plans more such transactions.Hwang’s private investment firm became the center of one of the biggest margin calls of all time late last month, and represented one of the most spectacular failures of risk-management and oversight in recent memory. The downfall of Archegos will result in $10 billion of losses to banks, according to analysts at JPMorgan Chase & Co. The debacle could attract regulatory scrutiny and potential fines for the banks involved, the analysts said this week.Read more: Archegos Ripples Through Banks’ Lucrative Hedge Fund BusinessTuesday’s block trades -- which sold at the lower end of ranges -- included 19 million Class A shares of Discovery sold at $38.40, said one of the people, asking not to be identified discussing a private matter. In addition, 22 million Class C shares of Discovery sold at $32.35 while a stake of 35 million Iqiyi shares went for $15.85.Credit Suisse’s latest sale comes weeks after several rivals dumped their shares to skirt losses. While the firm was one of several global investment banks to facilitate the leveraged bets of Archegos, it was slower than others to unwind the positions and had initially tried to reach some sort of standstill agreement, people familiar with the matter have said.The strategy failed as rivals rushed to cut their losses. Global banks including Goldman Sachs Group Inc. and Deutsche Bank AG have told investors that they shed their Archegos-linked positions with little financial impact.Credit Suisse is now planning a sweeping overhaul of its hedge fund business. It has already announced plans to cut its dividend, suspend share buybacks and scrap bonuses for top executives.(Updates with Credit Suisse shares from third paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Clinical Trial Packaging and Labelling Market Forecast 2020-2030

    Revenue Prospects by Type (Primary Packaging (Blisters, Bottles, Pouches, Tubes, Others), Secondary Packaging (Labelling for Parenteral and Injectable, Just in Time Labelling, Tyvek Blistering for Parenteral, Cartons, Others)), End Users (Drug Manufacturing Companies, Research Labs and CROs), Profiles of Leading Companies and Regional and Leading National Market Analysis.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clinical Trial Packaging and Labelling Market Forecast 2020-2030" - https://www.reportlinker.com/p06058481/?utm_source=GNW Clinical Trial Packaging and Labelling- our new study reveals trends, R&D progress, and predicted revenues Where is the Clinical Trial Packaging and Labelling market heading? If you are involved in this sector you must read this newly updated report. This report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there. Discover how to stay ahead Our 171 pages report provides 96 tables, 50 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Clinical Trial Packaging and Labelling Market. See how to exploit the opportunities. Forecasts to 2030 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments. Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level. Clinical Trial Packaging and Labelling Market by Type Primary Packaging • Blisters • Bottles • Pouches • Tubes • Others Secondary Packaging • Labelling for Parenteral and Injectable • Just in Time Labelling • Tyvek Blistering for Parenteral • Cartons • Others Clinical Trial Packaging and Labelling Market by End Users • CRO’s • Drug Manufacturing Companies • Research Labs In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets: North America • U.S. • Canada • Latin America: • Brazil • Mexico • Rest of Latin America Europe (EU) • Germany • France • UK • Italy • Spain • Rest of Europe Asia-Pacific (APAC) • Japan • China • India • Australia • ASEAN • Rest of Asia-Pacific Middle East and Africa (MEA) • GCC Countries • South Africa • Rest of MEA Leading companies and the potential for market growth Overall world revenue for Clinical Trial Packaging and Labelling Market will surpass $900 million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead. How the Clinical Trial Packaging and Labelling Market report helps you In summary, our 181 pages report provides you with the following knowledge: • Revenue forecasts to 2030 for 5 regional and 17 key national markets- See forecasts for the Clinical Trial Packaging and Labelling market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa. • Prospects for established firms and those seeking to enter the market- including company profiles for 13 of the major companies involved in the Clinical Trial Packaging and Labelling market Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence. Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Clinical Trial Packaging and Labelling market and leading companies. You will find data, trends and predictions.Read the full report: https://www.reportlinker.com/p06058481/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Global Asphalt Pavers Market Report 2020-2027: Market Size is Expected to Reach $1,410.03 Million - Strong Government Funding & Introduction of New Technologies

    Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Asphalt Pavers Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Screed Type; By Operating Weight; By Paving Width; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global asphalt pavers market size is expected to reach USD 1,410.03 million by 2027China is focusing on the development of its western region. In line with this, it has announced various infrastructure projects for the Tibet region as well. India is mainly focusing on the development of its transport network by investing heavily in road and rail infrastructure. Furthermore, the country is focusing on improving power infrastructure by building thermal, nuclear, wind, and solar power stations.Traffic has grown by 150 times over the last 50 years, while roads have increased by 9 times during the same period. The quality of roads in India is quite poor, leading to annual economic losses of US$ 4 Bn to US$ 7 Bn. The Indian construction equipment market has the potential to grow up to significantly, owing to the government's focus on infrastructure developments.Intelligent pavement refers to the pavement of asphalt using asphalt pavers equipped with global positioning systems (GPS) based mapping sensors and optional feedback controls. It is one of the most important progress made in roadway construction and has been widely adopted by Europe and China's manufacturers.In order to meet the changing need of the European market coupled with increasing demand for higher levels of operator comfort and safety. Despite their smaller dimensions, manufacturers are continuing to improve the operator's working environment by adding more comfort and safety features to their machines. For instance, Hamm's newly launched Asphalt Pavers enhance maximum possible operators' comfort, exceptionally good visibility, and the highest possible operational safety.Market participants such as Caterpillar, Sunroc Corporation, Astec Industry, Gencor Industries, Inc., Wirtgen group, Volvo CE, Ammann, Sumitomo, Fayat Group, Sany, Zoomlion, VT Leeboy, Shantui, and XCMG are some of the key players operating in the global market. Market players are focusing on mergers, acquisitions, technological advancements to have a competitive edge in the market. For instance, in July 2020, Gencor Industries announced a definitive agreement to acquire paver business from Blaw Knox, the Pennsylvania, U.S. based paver equipment manufacturer. Key Topics Covered: 1. Introduction2. Executive Summary3. Research Methodology3.1. Overview3.2. Data Sources4. Asphalt Pavers Market Insights4.1. Asphalt Pavers - Industry snapshot4.2. Asphalt Pavers Market Dynamics4.2.1. Drivers and Opportunities4.2.1.1. Strong government funding4.2.1.2. Introduction of new technologies4.2.2. Restraints and Challenges4.2.2.1. Cost escalations4.3. Porter's Five Forces Analysis4.4. PESTLE Analysis4.4.1. Asphalt Pavers Market Industry trends5. Asphalt Pavers Market Assessment by Product Type5.1. Key Findings5.2. Introduction5.3. Tracked Pavers5.4. Wheeled Pavers6. Global Asphalt Pavers Market, by Screed Type6.1. Key Findings6.2. Introduction6.3. Hydrostatic6.4. Mechanical7. Global Asphalt Pavers Market, by Operating Weight7.1. Key Findings7.2. Introduction7.3. 5000-8000 Kgs7.4. 8000-12000 Kgs7.5. 12000-15000 Kgs7.6. Over 15000 Kgs8. Asphalt Pavers Market Assessment by Paving Width8.1. Key Findings8.2. Introduction8.3. Up to 1.5 m8.4. 1.5-2.5 m8.5. 2.5-5 m8.6. Over 5 m9. Asphalt Pavers Market Assessment by Geography9.1. Key findings9.2. Introduction9.2.1. Asphalt Pavers Market Assessment, By Geography, 2016-2027 (USD Million)10. Competitive Landscape10.1. Expansion and Acquisition Analysis10.1.1. Expansion10.1.2. Acquisitions10.2. Partnerships/Collaborations/Agreements/Exhibitions11. Company Profiles11.1. Company Overview11.2. Financial Performance11.3. Product Benchmarking11.4. Recent Developments CaterpillarAstec IndustryWirtgen groupVolvo CEAmmannSumitomoFayat GroupSanyZoomlionVT LeeboyShantuiXCMG For more information about this report visit https://www.researchandmarkets.com/r/nmqivk CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • IEA ups oil demand forecast as vaccinations brighten outlook

    Vaccine rollouts are brightening the outlook for global oil demand, the International Energy Agency (IEA) said on Wednesday, though rising cases in some major oil-consuming countries show a recovery may be fragile. "Fundamentals look decidedly stronger," the IEA said in its monthly report. "The massive overhang in global oil inventories that built up during last year's COVID-19 demand shock is being worked off, vaccine campaigns are gathering pace and the global economy appears to be on a better footing."

  • Louisiana ship capsize: Search for survivors from 'lift' vessel

    Rescuers have so far saved six of the commercial ship's reported 18 crew members from the water.

  • Tesco profits dive 20% despite surging grocery sales during pandemic

    The supermarket giant said profits were weighed down by £892 million in coronavirus-related costs.

  • EU parliament again refuses to set date for ratifying Brexit trade deal amid concerns over UK conduct

    Senior MEP says ‘cool heads must prevail’ in holding UK to commitments

  • Civil groups want EU lawmakers to boost privacy rights in planned WhatsApp, Skype rules

    Amnesty International, Privacy International and 28 other civil and human rights groups on Wednesday urged EU lawmakers to take a strong stand on privacy rights in proposed rules governing Facebook's WhatsApp and Microsoft's Skype. The call by the group in a letter to the European Parliament, whose members are spread out across Europe, is in response to what they said are attempts by EU countries to weaken privacy rights. EU countries in February agreed to a joint position in forthcoming negotiations with EU lawmakers and the European Commission on an ePrivacy Regulation that would subject WhatsApp and Skype to the same rules as telecoms providers and restrict the tracking of users in order to provide personalised ads.

  • UPDATE 1-China Southern reviewing future of its A380 jets, says executive

    China Southern Airlines is reviewing the future of the five Airbus A380 superjumbos in its fleet, an executive said on Wednesday, at a time when many carriers are retiring the jets early because of the COVID-19 pandemic. "Not only for China Southern but also for many airlines we must be thinking about the A380," China Southern Senior Vice President International and Corporate Relations Wu Guoxiang said at a CAPA Centre for Aviation event. China Southern is the only Chinese A380 operator and is running only 10% of its overall pre-pandemic international capacity because of border restrictions, Wu said.

  • 46 Of The Best Thriller Films If You’re All About That Suspense

    From 2020 Oscar winner Parasite, which delves into the subjects of greed and class, to Rosamund Pike’s scene-stealing performance in psychological thriller Gone Girl, the best thrillers are the ones that seem so real they give us nightmares. Greta is a 2018 psychological thriller film which really gives us the heebie jeebies. It stars Isabelle Huppert (who plays a lonely widow named Greta) and Chloë Grace Moretz (a young woman named Frances) who become friends.

  • Young black people three times more likely to be unemployed than white peers

    Young black people are three times more likely to be out of work than white peers, research shows.

  • Clinical Trial Supply and Logistics Market for Pharma 2020-2030

    Forecasts by Type (Clinical Trial Manufacturing (Clinical Trial Packaging, Others), Clinical Trial Logistics and Distribution (Clinical Trial Cold Chain Logistics, Others), Clinical Trial Supply Chain Management), by End Users (CRO’s, Pharma & Biotech, Others (Academics, Research Institutes etc.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clinical Trial Supply and Logistics Market for Pharma 2020-2030" - https://www.reportlinker.com/p06058482/?utm_source=GNW )) PLUS COVID-19 Impact AnalysisThe global clinical trials supply and logistics market for pharma is estimated to have reach $10.3bn in 2019, dominated by the clinical trial manufacturing segment. The global clinical trial supply and logistics market for pharma is expected to grow at a CAGR of 6.6 % in the first half of the forecast period. This new report also covers the economic impact of COVID-19 as well as how the pandemic will affect your industry sector. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 178-page report you will receive 81 charts– all unavailable elsewhere. The 178-page report provides clear detailed insight into the global clinical trial supply and logistics market for pharma. Discover the key drivers and challenges affecting the market. The report also includes insight on how COVID-19 will affect your industry. By ordering and reading our brand-new report today you stay better informed and ready to act. Report Scope • Revenue and growth forecasts from 2020 to 2030 for the global clinical trial supply and logistics market. This report also discusses the Drivers and Restraints of the global clinical trial supply and logistics market. • Revenue and growth forecasts from 2020 to 2030 for the leading submarkets of the global clinical trial supply and logistics market: • Manufacturing – also with sub forecasting for packaging and for other production • Logistics and distribution – also with sub forecasts for cold chain logistics and for other services • Supply chain management This report discusses the Drivers and Restraints of each submarket. • Revenue and growth forecasts from 2019 to 2029 for the leading national markets: • United States • Japan • EU5: Germany, France, United Kingdom, Italy, Spain • Brazil • Mexico • China • India • GCC • South Africa • Rest of the World Revenues forecast for the US, Japan, EU5, Brazil, Mexico, China, India, GCC, South Africa are further broken down by submarket. • This report profiles the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry: • ADAllen Pharma • Almac Group • Amatsigroup • Catalent • DHL • FedEx • Fisher Clinical Services • Marken • Parexel International • Sharp Packaging Services, LLC • Many others • This report provides qualitative analysis of the clinical trial supply and logistics market. This report discusses the Strengths, Weaknesses, Opportunities and Threats of the clinical trial supply and logistics market. Social, Technological, Economic and Political factors that influence this market are also discussed. • This report discusses trends in the clinical trial supply and logistics market, clinical trial manufacturing market, comparator sourcing, clinical trial packaging, clinical trial supply chain management. • This report discusses the regulatory outlook of the clinical trial supply and logistics industry, outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials • Key Questions Answered by this Report: • How is the clinical trial supply and logistics market for pharma evolving? • What are the drivers and restraints for the growth of the clinical trial supply and logistics market for pharma? • How will each clinical trial supply and logistics submarket for pharma grow over the forecast period and how much revenue will these submarkets account for in 2030? • How will the market shares for each clinical trial supply and logistics submarket for pharma develop to 2030? • What is the value of the leading clinical trial supply and logistics submarket for pharma s in important regions of the world? • What will be the main driver for the overall market to 2030? • How will the market shares of the national markets change by 2030 and which geographical region will lead the market by 2030? • Who are the leading players and what are their prospects over the forecast period? This study is intended for anyone requiring commercial analyses for the global clinical trial supply and logistics market for pharma. You find data, trends and predictions.Read the full report: https://www.reportlinker.com/p06058482/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Staycay ready? The hot UK holiday rentals to book now

    The time has come, self-contained staycations are officially allowed again. Abha Shah picks the hottest listings to book now

  • Global Industrial Heating Equipment Market Analysis & Segment Forecasts to 2027: Growing Construction Industry and an Increase in Demand for Energy-Efficient Solutions are Likely to Stimulate Demand

    Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Industrial Heating Equipment Market Analysis By Product, By Application And Segment Forecasts, 2017-2026" report has been added to ResearchAndMarkets.com's offering. The growing construction industry and an increase in demand for energy-efficient solutions are likely to stimulate demand for industrial heating equipment.The Global Industrial Heating Equipment Market size is expected to reach USD 33.88 billion by 2027 After a disappointing trade flow in 2016-2017, global trade in the first half of 2018 has shown significant improvement owing to low global manufacturing output along with unstable crude oil prices. Moving forward, the vulnerability in raw material prices remains a concern, along with unpredictable trade policies adopted by major consumers and manufacturers. The chemical and mining sectors accounted for the largest share in the industrial heating equipment market. This has been calculated on the basis of chemical industries outlook for the future by precedence to a capacity addition of the chemical and the mineral, material, and mining industries. An increase in demand for residential buildings in developed economies, driven by low-interest rates, a decrease in unemployment rates, and low debt service ratios, will positively contribute to the construction activities, which will aid in the growth of the industrial heating equipment market.Further key findings from the report suggest The heat pump segment was valued at USD 2.53 billion in 2019 and is estimated to reach USD 3.46 billion by the end of the forecast period. The segment is anticipated to grow at a CAGR of 4% due to an exponential increase in the capacity of SMEs under the specialty chemical industry in Asia. This segment registered a decline in production by 11% during 2014-2016; however, it is expected to pick up the pace by the end of 2019.The U.S. region is expected to grow significantly during the forecast period at a CAGR of 4.6%. The industrial sector in the U.S. contributed to over 30% of the thermal demand in the region. In 2010, the petroleum refining and chemicals industries accounted for 31% and 20% of the total process heating energy use, respectively. The petroleum refining and chemical industries use more than 1 quad of energy each for process heating.The demand for thermal energy varies from 900 GJ to 3.6 TJ depending on the size of a refinery plant. The industrial manufacturing sector of Canada accounts for nearly 65% of the thermal energy demand. The paper & pulp and petroleum refining industries are the largest consumers of industrial heating equipment.Key participants in the industry include Danfoss, Ingersoll-Rand Plc, Lennox International, Inc., Daikin Industries Ltd., Robert Bosch GmbH, Johnson Controls, Uponor Corporation, United Technologies Corporation, Emerson Electric Co. and Honeywell International Inc.In 2018, Danfoss acquired shares in Finland-based developer and provider of turnkey IoT solutions, Leanheat. Danfoss plans to strengthen its global position in building energy optimization and management. Key Topics Covered: Chapter 1. Market SynopsisChapter 2. Executive SummaryChapter 3. Indicative MetricsChapter 4. Industrial Heating Equipment Market Segmentation & Impact Analysis4.1. Industrial Heating Equipment Segmentation Analysis4.2. Industrial Outlook4.3. Regulatory Framework4.4. Industrial Heating Equipment Market Impact Analysis4.4.1. Market driver analysis4.4.1.1. Growing Construction Industries4.4.1.2. Demand for energy efficient solutions4.4.2. Market restraint analysis4.4.2.1. High Costs4.5. Key opportunities prioritized4.6. ETOP Analysis4.7. Porter's Five Forces Analysis4.8. Competitive Metric Space Analysis4.9. Price trend AnalysisChapter 5. Industrial Heating Equipment Market By Product Insights & Trends5.1. Product Dynamics & Market Share, 2018 & 20265.2. Heat Pumps5.3. Furnaces5.4. Unitary Heaters5.5. Boilers5.6. Radiant HeatersChapter 6. Industrial Heating Equipment Market By Application Insights & Trends6.1. Application Dynamics & Market Share, 2018 & 20266.2. Oil & Gas6.3. Mining Materials & Metals6.4. Machinery Manufacturing Industry6.5. Automotive6.6. ChemicalChapter 7. Industrial Heating Equipment Market Regional Outlook7.1. Industrial Heating Equipment Market share by region, 2018 & 2026Chapter 8. Competitive Landscape8.1. Market Revenue Share by Manufacturers8.2. Manufacturing Cost Breakdown Analysis8.3. Mergers & Acquisitions8.4. Market positioning8.5. Strategy Benchmarking8.6. Vendor LandscapeChapter 9. Company Profiles DanfossUnited Technologies CorporationIngersoll-Rand PlcLennox International Inc.Daikin Industries Ltd.Johnson ControlsRobert Bosch GmbHUponor CorporationEmerson Electric Co.Honeywell International Inc. For more information about this report visit https://www.researchandmarkets.com/r/8qgmjc CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • UPDATE 1-Thailand reports daily record of over 1,300 new coronavirus cases

    Thailand reported on Wednesday 1,335 new COVID-19 cases, the biggest daily rise since the start of the pandemic and the third record rise this week, as the Southeast Asian country struggles with a new wave of infections. The spike in cases comes as Thais celebrate the Songkran new year holidays and authorities have urged people to avoid unnecessary travel and reduce gatherings to help limit the outbreak, which includes the highly transmissible B.1.1.7 variant first identified in Britain. "The period after Songkran is a critical time to control the outbreak, if not we could see 10,000 to 20,000 cases per day," senior health official, Opas Karnkawinpong, said, urging people to work from home for two weeks after the holidays.